Comments on the NMDA antagonist memantine.
Fischhof
P K
PK
Wagner-Jauregg Institute for Clinical and Experimental Gerontopsychiatry, Geriatric Center am Wienerwald, Vienna, Austria. peter.fischhof@univie.ac.at
D000368:Aged; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy*; D015259:Dopamine Agents / Q000627:therapeutic use*; D006801:Humans; D008559:Memantine / Q000627:therapeutic use*; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*
D015259:Dopamine Agents; D016202:N-Methylaspartate; D008559:Memantine